نتائج البحث 691-700 من 19399 لعملية البحث عن Two-phase
... stage glioma tumors and evaluate response to therapy. ... This randomized phase III trial compares ... 2-year progression free survival (PFS) rate as compared to ...
The purpose of this study is to determine the maximum tolerated dose (MTD) and schedule and/or a recommended Phase 2 dose (RP2D) and schedule of KTX-1001 ...
... stage glioma tumors and evaluate response to therapy. ... This randomized phase III trial compares ... توجّه للصفحة 22 · توجّه للصفحة 33 · توجّه للصفحة 44 ...
Rochester, Minn. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a ...
This phase II trial studies how well inotuzumab ozogamicin works in ... This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of ...
You will be in this study for two years. There is potential to continue to monitor your progress with lifelong regular visits as part of your standard of ...
... phase 2 dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma.
Page 1. Page 2.
This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.